SelectQuote(SLQT)

搜索文档
SLQT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages SelectQuote, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SLQT
Globenewswire· 2025-09-28 22:00
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...
SLQT Deadline: SLQT Investors Have Opportunity to Lead SelectQuote, Inc. Securities Fraud Lawsuit
Prnewswire· 2025-09-27 21:00
Accessibility StatementSkip Navigation NEW YORK, Sept. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the "Class Period"), of the important October 10, 2025 lead plaintiff deadline. So what: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs thr ...
SLQT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages SelectQuote, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SLQT
Globenewswire· 2025-09-25 21:42
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...
Deadline Alert: SelectQuote, Inc. (SLQT) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Globenewswire· 2025-09-25 17:22
LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR SELECTQUOTE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAI ...
SelectQuote, Inc. Stockholders Who Suffered Losses Should Contact Robbins LLP for Information About Leading the Class Action Against SLQT
Prnewswire· 2025-09-25 00:47
Accessibility StatementSkip Navigation SAN DIEGO, Sept. 24, 2025 /PRNewswire/ -- Robbins LLPÂ reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired SelectQuote, Inc. (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025. SelectQuote is an insurance broker which sells Medicare Advantage and other health insurance plans online and by telephone. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbi ...
SELECTQUOTE ALERT: Bragar Eagel & Squire, P.C. Reminds SelectQuote Investors of the October 10th Deadline
Globenewswire· 2025-09-24 21:33
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SelectQuote (SLQT) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- What’s Happe ...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SelectQuote
Prnewswire· 2025-09-24 15:05
Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in SelectQuote between September 9, 2020 and May 1, 2025and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). [You may also click here for additional i ...
SelectQuote, Inc. Partners with Findhelp to Connect Nearly 50,000 Seniors with Vital Social Services
Businesswire· 2025-09-23 20:15
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced a significant milestone in its partnership with Findhelp, a closed-loop referral management software company at the forefront of powering the U.S. safety net. SelectQuote has directed more than 200,000 low-income seniors, and Findhelp has provided free and reduced-cost social services, addressing cri. ...
SelectQuote, Inc. INVESTOR ALERT: Kirby McInerney LLP Notifies SelectQuote, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
Businesswire· 2025-09-16 19:47
NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds SelectQuote, Inc. ("SelectQuote†or the "Company†) (NYSE:SLQT) investors of the October 10, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action. If you purchased or otherwise acquired SelectQuote securities, have information, or would like to learn more, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the form below, to discuss your rights or i. ...
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune and SelectQuote that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
Globenewswire· 2025-09-15 11:14
Altimmune集体诉讼事件 - 公司因Pemvidutide治疗MASH的IMPACT Phase 2b试验未达到主要终点统计显著性而面临集体诉讼 试验显示纤维化改善呈积极趋势但未能实现统计显著性 原因为安慰剂反应高于预期 [2] - 公司高管在结果公布后回应冷淡 将失败归因于二期试验性质 并称期待三期试验获得更好结果 [2] - 股价在2025年6月26日单日暴跌53.2% 从6月25日收盘价7.71美元/股跌至3.61美元/股 [3] SelectQuote集体诉讼事件 - 美国司法部于2025年5月1日提起《虚假申报法》诉讼 指控公司在2016至2021年间通过收取保险公司数千万美元非法回扣操纵医疗保险计划推荐 [3] - 公司被指控与主要保险公司合谋歧视被视为利润较低的参保人(包括残障人士)并虚假宣传提供无偏见保险比较 [3] - 股价在诉讼日下跌19.2% 跌0.61美元至2.56美元/股 交易量异常放大 [3] - 诉讼指控公司在整个集体诉讼期隐瞒关键事实 包括未披露按回扣水平推荐保险计划、违反法律法规及面临法律制裁风险等 [4] 诉讼程序信息 - Altimmune集体诉讼期覆盖2023年8月10日至2025年6月25日 首席原告截止日期为2025年10月6日 [2] - SelectQuote集体诉讼期覆盖2020年9月9日至2025年5月1日 首席原告截止日期为2025年10月10日 [3]